0001209191-14-072480.txt : 20141202
0001209191-14-072480.hdr.sgml : 20141202
20141202190130
ACCESSION NUMBER: 0001209191-14-072480
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141201
FILED AS OF DATE: 20141202
DATE AS OF CHANGE: 20141202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celladon Corp
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330971591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11988 EL CAMINO REAL
STREET 2: SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-366-4288
MAIL ADDRESS:
STREET 1: 11988 EL CAMINO REAL
STREET 2: SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TAKEYA RYAN K
CENTRAL INDEX KEY: 0001590702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 141261811
MAIL ADDRESS:
STREET 1: C/O CELLADON CORPORATION
STREET 2: 12760 HIGH BLUFF DRIVE, SUITE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-01
0
0001305253
Celladon Corp
CLDN
0001590702
TAKEYA RYAN K
11988 EL CAMINO REAL, SUITE 650
SAN DIEGO
CA
92130
0
1
0
0
VP, Manufacturing
Common Stock
2014-12-01
4
M
0
7777
1.12
A
8354
D
Common Stock
2014-12-01
4
S
0
7777
12.01
D
577
D
Stock option (right to buy)
1.12
2014-12-01
4
M
0
7777
0.00
D
2013-01-27
2022-06-14
Common Stock
7777
95349
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.81 to $12.29 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The amount includes shares purchased under Celladon's employee stock purchase plan prior to the reported transaction.
25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.
/s/ Rebecque J. Laba, Attorney-in-Fact
2014-12-02